Targeting the pathophysiology of diabetic macular edema
- PMID: 20980428
- PMCID: PMC2963519
- DOI: 10.2337/dc10-1580
Targeting the pathophysiology of diabetic macular edema
Comment on
-
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.Diabetes Care. 2010 Nov;33(11):2399-405. doi: 10.2337/dc10-0493. Diabetes Care. 2010. PMID: 20980427 Free PMC article. Clinical Trial.
References
-
- Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy: XV: the long-term incidence of macular edema. Ophthalmolog 1995;102:7–16 - PubMed
-
- Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009;54:1–32 - PubMed
-
- Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 1983;90:1301–1317 - PubMed
-
- Early Treatment Diabetic Retinopathy Study R. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Early Treatment Diabetic Retinopathy Study research group Arch Ophthalmol 1985;103:1796–1806 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical